サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：心血管超音波の世界市場：予測（2022年～2030年）
市場調査レポート
商品コード
1108346

心血管超音波の世界市場：予測（2022年～2030年）

Global Cardiovascular Ultrasound Market Forecast 2022-2030
出版日: | 発行: Inkwood Research | ページ情報: 英文 235 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.53円
心血管超音波の世界市場：予測（2022年～2030年）
出版日: 2022年08月01日
発行: Inkwood Research
ページ情報: 英文 235 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の心血管超音波の市場規模は、予測期間中に5.90%のCAGRで拡大すると予測されています。

当レポートでは、世界の心血管超音波市場について調査し、市場の概要とともに、COVID-19の影響、ディスプレイ別、技術別、タイプ別、エンドユーザー別、地域別の動向、競合情勢、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 調査範囲と調査手法

第2章 エグゼクティブサマリー

第3章 市場力学

  • 主な促進要因
  • 主な抑制要因

第4章 主要な分析

  • COVID-19に与える影響
  • 動向
  • ポーターのファイブフォース分析
  • 機会マトリクス
  • ベンダー情勢
  • バリューチェーン分析
  • 主な購入基準
  • 規制の枠組み

第5章 ディスプレイ別市場

  • 白黒
  • カラー

第6章 技術別市場

  • 二次元
  • 3D/4D
  • ドップラー

第7章 タイプ別市場

  • 経胸壁心エコー検査
  • 胎児心エコー検査
  • 経食道心エコー検査
  • その他

第8章 エンドユーザー別市場

  • 病院
  • 診断センター
  • 外来診療センター
  • その他

第9章 地域分析

  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第10章 競合情勢

  • 主要な戦略的展開
    • 製品の発売と開発
    • パートナーシップと契約
  • 企業プロファイル
    • CANON MEDICAL SYSTEMS CORPORATION
    • CLARIUS
    • DAWEI MEDICAL
    • ESAOTE SPA
    • FUJIFILM HOLDINGS CORPORATION
    • GE HEALTHCARE
    • LANMAGE
    • LELTEK
    • MINDRAY MEDICAL INTERNATIONAL LIMITED
    • PHILIPS HEALTHCARE
    • SAMSUNG MEDISON CO LTD
    • SIEMENS HEALTHINEERS
    • TELEMED ULTRASOUND MEDICAL SYSTEMS
    • VIATOM TECHNOLOGY CO
    • ZONCARE
図表

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - CARDIOVASCULAR ULTRASOUND
  • TABLE 2: REGULATORY FRAMEWORK
  • TABLE 3: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY DISPLAY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 4: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY DISPLAY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 5: GLOBAL BLACK AND WHITE MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 6: GLOBAL BLACK AND WHITE MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 7: GLOBAL COLOR MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 8: GLOBAL COLOR MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 9: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 10: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY TECHNOLOGY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 11: GLOBAL 2D MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 12: GLOBAL 2D MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 13: GLOBAL 3D/4D MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 14: GLOBAL 3D/4D MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 15: GLOBAL DOPPLER MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 16: GLOBAL DOPPLER MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 17: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 18: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 19: GLOBAL TRANSTHORACIC ECHOCARDIOGRAPHY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 20: GLOBAL TRANSTHORACIC ECHOCARDIOGRAPHY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 21: GLOBAL FETAL ECHOCARDIOGRAPHY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 22: GLOBAL FETAL ECHOCARDIOGRAPHY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 23: GLOBAL TRANSESOPHAGEAL ECHOCARDIOGRAPHY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 24: GLOBAL TRANSESOPHAGEAL ECHOCARDIOGRAPHY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 25: GLOBAL OTHER TYPES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 26: GLOBAL OTHER TYPES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 27: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 28: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY END-USER, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 29: GLOBAL HOSPITALS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 30: GLOBAL HOSPITALS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 31: GLOBAL DIAGNOSTIC CENTERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 32: GLOBAL DIAGNOSTIC CENTERS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 33: GLOBAL AMBULATORY CARE CENTERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 34: GLOBAL AMBULATORY CARE CENTERS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 35: GLOBAL OTHER END-USERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 36: GLOBAL OTHER END-USERS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 37: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 38: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY GEOGRAPHY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 39: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 40: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 41: LEADING PLAYERS OPERATING IN NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET
  • TABLE 42: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 43: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 44: LEADING PLAYERS OPERATING IN EUROPE CARDIOVASCULAR ULTRASOUND MARKET
  • TABLE 45: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 46: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 47: LEADING PLAYERS OPERATING IN ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET
  • TABLE 48: REST OF WORLD CARDIOVASCULAR ULTRASOUND MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 49: REST OF WORLD CARDIOVASCULAR ULTRASOUND MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 50: LEADING PLAYERS OPERATING IN REST OF WORLD CARDIOVASCULAR ULTRASOUND MARKET
  • TABLE 51: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
  • TABLE 52: LIST OF PARTNERSHIPS & AGREEMENTS

LIST OF FIGURES

  • FIGURE 1: KEY MARKET TRENDS
  • FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: VALUE CHAIN ANALYSIS
  • FIGURE 6: KEY BUYING CRITERIA
  • FIGURE 7: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, GROWTH POTENTIAL, BY DISPLAY, IN 2021
  • FIGURE 8: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY BLACK AND WHITE, 2022-2030 (IN $ MILLION)
  • FIGURE 9: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY COLOR, 2022-2030 (IN $ MILLION)
  • FIGURE 10: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, GROWTH POTENTIAL, BY TECHNOLOGY, IN 2021
  • FIGURE 11: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY 2D, 2022-2030 (IN $ MILLION)
  • FIGURE 12: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY 3D/4D, 2022-2030 (IN $ MILLION)
  • FIGURE 13: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY DOPPLER, 2022-2030 (IN $ MILLION)
  • FIGURE 14: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, GROWTH POTENTIAL, BY TYPE, IN 2021
  • FIGURE 15: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY TRANSTHORACIC ECHOCARDIOGRAPHY, 2022-2030 (IN $ MILLION)
  • FIGURE 16: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY FETAL ECHOCARDIOGRAPHY, 2022-2030 (IN $ MILLION)
  • FIGURE 17: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY TRANSESOPHAGEAL ECHOCARDIOGRAPHY, 2022-2030 (IN $ MILLION)
  • FIGURE 18: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY OTHER TYPES, 2022-2030 (IN $ MILLION)
  • FIGURE 19: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, GROWTH POTENTIAL, BY END-USER, IN 2021
  • FIGURE 20: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY HOSPITALS, 2022-2030 (IN $ MILLION)
  • FIGURE 21: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY DIAGNOSTIC CENTERS, 2022-2030 (IN $ MILLION)
  • FIGURE 22: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY AMBULATORY CARE CENTERS, 2022-2030 (IN $ MILLION)
  • FIGURE 23: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY OTHER END-USERS, 2022-2030 (IN $ MILLION)
  • FIGURE 24: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
  • FIGURE 25: UNITED STATES CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 26: CANADA CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 27: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
  • FIGURE 28: UNITED KINGDOM CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 29: GERMANY CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 30: FRANCE CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 31: ITALY CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 32: SPAIN CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 33: NORDIC COUNTRIES CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 34: REST OF EUROPE CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 35: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
  • FIGURE 36: CHINA CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 37: JAPAN CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 38: INDIA CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 39: SOUTH KOREA CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 40: INDONESIA CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 41: SINGAPORE CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 42: TAIWAN CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 43: AUSTRALIA & NEW ZEALAND CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 44: REST OF ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 45: REST OF WORLD CARDIOVASCULAR ULTRASOUND MARKET, REGIONAL OUTLOOK, 2021 & 2030 (IN %)
  • FIGURE 46: LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 47: MIDDLE EAST & AFRICA CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
目次
Product Code: 16323

KEY FINDINGS

The global cardiovascular ultrasound market growth is anticipated to progress at a CAGR of 5.90% during the forecast period. The primary growth drivers include technological advancements and the increasing number of cardiovascular diseases.

MARKET INSIGHTS

Cardiovascular ultrasound includes the ultrasound imaging of a rapidly moving complex organ positioned deep within the human body, the heart. These devices are central diagnostic equipment that can aid in minimizing the incidences of stroke and heart attack through an early diagnosis. As a result, the rising prevalence of heart problems is one of the key growth drivers of the global cardiovascular ultrasound market.

The growing prevalence of cardiovascular diseases like coronary disease and heart attack is set to raise the demand for cardiovascular ultrasound applications since they utilize sound waves to create images of the heart for assessing the heart's overall health. As per the American College of Cardiology Foundation, around 1.05 million suffered from coronary diseases in the US in 2019. In addition, almost 805,000 Americans have a heart attack annually, according to the Centers for Disease Control and Prevention (CDC). Such aspects propel the global cardiovascular ultrasound market growth. However, the market growth is restrained by stringent regulations.

REGIONAL INSIGHTS

The global cardiovascular ultrasound market growth analysis includes the evaluation of Asia-Pacific, Europe, North America, and Rest of World. Asia-Pacific is the fastest-growing region in the global market, attributed to the growing geriatric population and the lifestyle changes that raise the risk of cardiovascular diseases.

COMPETITIVE INSIGHTS

The market is fragmented since the main players do not possess a major share. Nevertheless, the competitive rivalry is high since companies launch new products with innovative features. Some of the eminent companies in the market include GE Healthcare, Philips Healthcare, Siemens Healthineers, Samsung Medison Co Ltd, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation caters to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. RISING CARDIOVASCULAR DISEASES
    • 3.1.2. TECHNOLOGICAL ADVANCEMENTS
  • 3.2. KEY RESTRAINTS
    • 3.2.1. LACK OF AWARENESS AMONG PATIENTS
    • 3.2.2. STRINGENT REGULATIONS

4. KEY ANALYTICS

  • 4.1. IMPACT OF COVID-19 ON CARDIOVASCULAR ULTRASOUND MARKET
  • 4.2. KEY MARKET TRENDS
  • 4.3. PORTER'S FIVE FORCES ANALYSIS
    • 4.3.1. BUYERS POWER
    • 4.3.2. SUPPLIERS POWER
    • 4.3.3. SUBSTITUTION
    • 4.3.4. NEW ENTRANTS
    • 4.3.5. INDUSTRY RIVALRY
  • 4.4. OPPORTUNITY MATRIX
  • 4.5. VENDOR LANDSCAPE
  • 4.6. VALUE CHAIN ANALYSIS
  • 4.7. KEY BUYING CRITERIA
    • 4.7.1. QUALITY
    • 4.7.2. DURABILITY
    • 4.7.3. PRICE
    • 4.7.4. TECHNOLOGY
  • 4.8. REGULATORY FRAMEWORK

5. MARKET BY DISPLAY

  • 5.1. BLACK AND WHITE
  • 5.2. COLOR

6. MARKET BY TECHNOLOGY

  • 6.1. 2D
  • 6.2. 3D/4D
  • 6.3. DOPPLER

7. MARKET BY TYPE

  • 7.1. TRANSTHORACIC ECHOCARDIOGRAPHY
  • 7.2. FETAL ECHOCARDIOGRAPHY
  • 7.3. TRANSESOPHAGEAL ECHOCARDIOGRAPHY
  • 7.4. OTHER TYPES

8. MARKET BY END-USER

  • 8.1. HOSPITALS
  • 8.2. DIAGNOSTIC CENTERS
  • 8.3. AMBULATORY CARE CENTERS
  • 8.4. OTHER END-USERS

9. GEOGRAPHICAL ANALYSIS

  • 9.1. NORTH AMERICA
    • 9.1.1. MARKET SIZE & ESTIMATES
    • 9.1.2. KEY GROWTH ENABLERS
    • 9.1.3. KEY CHALLENGES
    • 9.1.4. KEY PLAYERS
    • 9.1.5. COUNTRY ANALYSIS
      • 9.1.5.1. UNITED STATES
      • 9.1.5.2. CANADA
  • 9.2. EUROPE
    • 9.2.1. MARKET SIZE & ESTIMATES
    • 9.2.2. KEY GROWTH ENABLERS
    • 9.2.3. KEY CHALLENGES
    • 9.2.4. KEY PLAYERS
    • 9.2.5. COUNTRY ANALYSIS
      • 9.2.5.1. UNITED KINGDOM
      • 9.2.5.2. GERMANY
      • 9.2.5.3. FRANCE
      • 9.2.5.4. ITALY
      • 9.2.5.5. SPAIN
      • 9.2.5.6. NORDIC COUNTRIES
      • 9.2.5.7. REST OF EUROPE
  • 9.3. ASIA-PACIFIC
    • 9.3.1. MARKET SIZE & ESTIMATES
    • 9.3.2. KEY GROWTH ENABLERS
    • 9.3.3. KEY CHALLENGES
    • 9.3.4. KEY PLAYERS
    • 9.3.5. COUNTRY ANALYSIS
      • 9.3.5.1. CHINA
      • 9.3.5.2. JAPAN
      • 9.3.5.3. INDIA
      • 9.3.5.4. SOUTH KOREA
      • 9.3.5.5. INDONESIA
      • 9.3.5.6. SINGAPORE
      • 9.3.5.7. TAIWAN
      • 9.3.5.8. AUSTRALIA & NEW ZEALAND
      • 9.3.5.9. REST OF ASIA-PACIFIC
  • 9.4. REST OF WORLD
    • 9.4.1. MARKET SIZE & ESTIMATES
    • 9.4.2. KEY GROWTH ENABLERS
    • 9.4.3. KEY CHALLENGES
    • 9.4.4. KEY PLAYERS
    • 9.4.5. COUNTRY ANALYSIS
      • 9.4.5.1. LATIN AMERICA
      • 9.4.5.2. MIDDLE EAST & AFRICA

10. COMPETITIVE LANDSCAPE

  • 10.1. KEY STRATEGIC DEVELOPMENTS
    • 10.1.1. PRODUCT LAUNCHES & DEVELOPMENTS
    • 10.1.2. PARTNERSHIPS & AGREEMENTS
  • 10.2. COMPANY PROFILES
    • 10.2.1. CANON MEDICAL SYSTEMS CORPORATION
    • 10.2.2. CLARIUS
    • 10.2.3. DAWEI MEDICAL
    • 10.2.4. ESAOTE SPA
    • 10.2.5. FUJIFILM HOLDINGS CORPORATION
    • 10.2.6. GE HEALTHCARE
    • 10.2.7. LANMAGE
    • 10.2.8. LELTEK
    • 10.2.9. MINDRAY MEDICAL INTERNATIONAL LIMITED
    • 10.2.10. PHILIPS HEALTHCARE
    • 10.2.11. SAMSUNG MEDISON CO LTD
    • 10.2.12. SIEMENS HEALTHINEERS
    • 10.2.13. TELEMED ULTRASOUND MEDICAL SYSTEMS
    • 10.2.14. VIATOM TECHNOLOGY CO
    • 10.2.15. ZONCARE